Guangdong Litai Pharmaceutical

Guangdong Litai Pharmaceutical is a prominent Chinese pharmaceutical enterprise focused on the development and manufacturing of large-volume parenterals (LVP) and intravenous solutions. The company is particularly recognized for its extensive line of amino acid injections, which are used for clinical nutritional support, as well as a variety of electrolyte and anti-infective infusions. Headquartered in Puning, Guangdong, it maintains large-scale production facilities that adhere to national GMP standards. Litai Pharmaceutical serves a broad network of hospitals and medical institutions across China, providing essential medicines such as metronidazole and levofloxacin injections. The company was previously listed on the National Equities Exchange and Quotations (NEEQ) under the symbol 835186.